EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical Evaluation of the TBI Assay in a Representative Emergency Department Cohort

Catherine M Mills, Nathan Roberts, Katelyn Fritsche, Drew Merideth, Nikolina Babic iD

The Journal of Applied Laboratory Medicine · 2026

DOI: 10.1093/jalm/jfaf159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2026. Verfasst von Catherine M Mills und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States. Hauptthemen laut MEDLINE: Emergency Service, Hospital, Biomarkers, Brain Injuries, Traumatic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Abbott.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Each year, millions of adults present to emergency departments (EDs) with suspected traumatic brain injury (TBI). While more than 80% undergo computed tomography (CT) imaging, the current gold standard for diagnosis, fewer than 10% are found to have acute intracranial abnormalities requiring immediate clinical intervention. This overuse of CT imaging increases costs, length of stay (LOS), and ED crowding. Immunoassays utilizing blood-based biomarkers associated with TBI have shown promise in identifying patients presenting with suspected mild traumatic brain injury (mTBI) who are at low risk for intracranial injury, potentially reducing unnecessary CT scans and ED LOS. The Abbott TBI assay may offer a scalable diagnostic solution; however, real-world performance data remain limited.

Methods

Remnant blood specimens were collected from ED patients being evaluated for mTBI with noncontrast CT imaging. These samples were analyzed using the Abbott TBI immunoassay on the Alinity i system, and patient charts were reviewed by 3 independent ED physicians. Analytical and clinical performance of the assay were evaluated.

Results

The TBI immunoassay demonstrated a sensitivity (95% CI) of 100.0% (67.6, 100.0) and specificity of 32.6% (23.7, 42.9) overall, with a 100% negative predictive value and 12% (10, 13) positive predictive value. Stratification by age showed a higher specificity of 47.2% (34.3, 60.3) in patients <65 years compared to 11.0% (4.4, 25.3) for patients ≥65 years.

Conclusions

The TBI assay on the Alinity i platform demonstrated excellent sensitivity but showed limited specificity, particularly in patients >65 years. Our findings support the safe use of the TBI assay as a rule-out tool in the ED.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Emergency Service, HospitalBiomarkersBrain Injuries, TraumaticHumansMaleFemaleAdultTomography, X-Ray ComputedMiddle AgedImmunoassaySensitivity and SpecificityAgedYoung Adult

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States.
  • Department of Emergency Medicine, Medical University of South Carolina, Charleston, SC, United States.

ORCID-Profile: Nikolina Babic

Förderung

  • Abbott

Zitieren

APA

Mills, C. M., Roberts, N., Fritsche, K., Merideth, D., & Babic, N. (2026). Clinical Evaluation of the TBI Assay in a Representative Emergency Department Cohort. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfaf159

Vancouver

Mills CM, Roberts N, Fritsche K, Merideth D, Babic N. Clinical Evaluation of the TBI Assay in a Representative Emergency Department Cohort. The Journal of Applied Laboratory Medicine. 2026. doi:10.1093/jalm/jfaf159

BibTeX
@article{Mills2026,
  author = {Mills, Catherine M and Roberts, Nathan and Fritsche, Katelyn and Merideth, Drew and Babic, Nikolina},
  title = {Clinical Evaluation of the TBI Assay in a Representative Emergency Department Cohort},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2026},
  doi = {10.1093/jalm/jfaf159}
}
Kostenlos starten →